Deal Structure Guide · Speech Therapy Practice

How to Structure a Speech Therapy Practice Acquisition

From SBA-backed buyouts to earnout arrangements and equity rollovers — understand every deal structure option for buying or selling an SLP practice in the $1M–$5M revenue range.

Acquiring a speech therapy practice involves navigating a unique set of deal structure considerations that differ meaningfully from general business acquisitions. Because practice value is often tied to licensed clinician relationships, referral source durability, and payer mix stability, the way a deal is structured must account for transition risk, staff retention, and revenue continuity after the owner exits. Most speech therapy practice transactions in the lower middle market close between 3.5x–6x EBITDA, with the final multiple heavily influenced by owner independence, clinician team depth, and diversification of payer and referral sources. Buyers — whether individual SLPs using SBA financing, PE-backed therapy platform roll-ups, or multi-specialty operators — will approach structuring differently based on their risk tolerance and integration plans. Sellers who understand the mechanics of deal structure are better positioned to maximize exit value, protect staff, and negotiate terms that reflect the true quality of their practice. This guide breaks down the most common deal structures used in speech therapy practice acquisitions, with realistic scenarios, negotiation tactics, and answers to the questions buyers and sellers ask most.

Find Speech Therapy Practice Businesses For Sale

SBA 7(a) Full Buyout with Seller Note Standby

The most common structure for individual buyers acquiring a speech therapy practice. An SBA 7(a) loan covers 80–90% of the purchase price, with the buyer contributing 10–20% equity. The seller may carry a subordinated note for 5–10% of the purchase price, which is typically placed on a 2-year standby during the SBA loan repayment period. This structure allows the seller to receive a near-full cash-out at closing while giving the buyer access to long-term, low-interest financing.

SBA loan: 80–90% | Buyer equity: 10–20% | Seller note: 5–10% (subordinated, 2-year standby)

Pros

Seller receives the majority of proceeds at closing with minimal deferred risk
Buyer benefits from SBA's 10-year repayment terms and competitive interest rates, making debt service manageable against practice cash flow
Seller note demonstrates seller confidence in the practice's ongoing performance, which can accelerate SBA lender approval

Cons

SBA underwriting requires clean, accrual-based financials and a documented owner transition plan — practices with messy books or heavy owner clinical dependency face delays or denials
Seller note is subordinated and on standby, meaning the seller cannot receive payments until the SBA loan is in good standing, typically for 24 months
SBA eligibility rules limit ownership and affiliation structures, which may complicate deals involving PE-backed acquirers or existing therapy platform roll-ups

Best for: Individual SLP buyers or first-time healthcare business owners acquiring a practice with $1M–$5M in revenue, clean financials, and an owner willing to transition over 6–12 months

Earnout Tied to Revenue and Clinician Retention

A portion of the purchase price is deferred and paid to the seller based on achieving specific performance milestones over 12–18 months post-close. In speech therapy acquisitions, earnouts are most commonly tied to total revenue retention, the retention of employed SLPs above a threshold headcount, or continuity of key referral relationships such as school district contracts. Earnouts are typically used when there is meaningful uncertainty about how revenue will perform without the founding clinician's direct involvement.

Base price at close: 75–85% | Earnout: 15–25% of total purchase price paid over 12–18 months based on defined metrics

Pros

Reduces buyer risk when the seller is central to clinical operations or referral relationships that have not yet been fully transitioned
Motivates the seller to actively support staff retention, referral continuity, and patient handoffs during the transition period
Allows both parties to bridge a valuation gap — buyer pays full price only if performance is validated post-close

Cons

Earnout disputes are common, particularly around how revenue is attributed, what counts as a retained clinician, or whether referral source changes were within the seller's control
Sellers who plan to reduce clinical hours sharply after close may find earnout milestones difficult to achieve without continued engagement
Complex to administer — requires clear contractual definitions, agreed-upon accounting methodology, and a dispute resolution mechanism

Best for: Acquisitions where the owner SLP drives more than 30% of billable hours or holds primary relationships with major referral sources such as school district administrators or ENT physician groups

Equity Rollover with Transition Role

The seller retains a minority equity stake — typically 10–20% — in the practice entity after the transaction closes, with the buyer acquiring a controlling interest. The seller continues in a defined role, such as clinical director or referral development advisor, for 12–24 months to support continuity. This structure is most common with PE-backed therapy platforms pursuing roll-up strategies, where the seller's ongoing involvement and stake alignment are viewed as critical to preserving practice value post-acquisition.

Buyer acquires 80–90% controlling interest at close | Seller retains 10–20% equity with defined buyout timeline or liquidity event trigger

Pros

Aligns seller and buyer incentives — the seller participates in future upside if the practice grows under new ownership or is eventually sold at a higher multiple
Reduces integration risk for buyers by keeping the founding clinician engaged during a structured handoff period with clear role boundaries
Attractive to sellers who are not ready for a clean break and want to remain connected to the clinical team and community they built

Cons

Sellers retain exposure to business risk post-close and may disagree with new ownership decisions around hiring, billing practices, or expansion strategy
Defining the seller's post-close role clearly is critical — vague clinical director titles without defined responsibilities create friction and confusion for staff
Exit timeline for the retained equity stake depends on a future liquidity event, which may be years away and subject to platform-level decisions outside the seller's control

Best for: PE-backed therapy platform acquisitions or multi-specialty group roll-ups where the seller's community reputation, referral relationships, and clinical leadership have significant standalone value

Asset Purchase with Consulting Agreement

The buyer acquires specific business assets — including patient records (with appropriate HIPAA-compliant transfer protocols), equipment, lease assignments, referral relationships, and goodwill — rather than the legal entity itself. The seller enters a paid consulting or employment agreement for 6–12 months post-close to support patient and referral transitions. This structure is common when the seller's entity has legacy liability exposure, unresolved billing audits, or Medicaid compliance concerns that make a stock purchase inadvisable.

Full purchase price paid at close for defined assets | Consulting agreement: $5,000–$15,000/month for 6–12 months, negotiated separately from purchase price

Pros

Buyer avoids inheriting unknown liabilities — billing audit exposure, unresolved insurance disputes, or HIPAA violations — that may be embedded in the seller's legal entity
Consulting agreement structure clearly compensates the seller for transition support while keeping responsibilities defined and time-limited
Allows the buyer to establish fresh insurance credentialing and payer contracts under the acquiring entity, which may improve reimbursement rates

Cons

Insurance credentialing re-enrollment under the new entity can take 60–120 days, creating a revenue gap during transition that must be planned for and funded
Patient record transfers require strict HIPAA compliance including patient notifications and business associate agreements — administrative burden is significant
Seller may resist asset structures if they result in unfavorable tax treatment compared to a stock sale, requiring careful negotiation of price or structure adjustments

Best for: Acquisitions where the seller's entity has compliance history concerns, Medicaid audit exposure, or outdated EHR systems that would create liability if assumed by the buyer

Sample Deal Structures

Individual SLP Buyer Acquiring a 4-Therapist Pediatric Practice Using SBA Financing

$2,100,000

SBA 7(a) loan: $1,680,000 (80%) | Buyer equity injection: $315,000 (15%) | Seller note on standby: $105,000 (5%)

SBA loan at current WSJ Prime + 2.75% over 10 years; seller note at 6% interest with 2-year standby, then monthly amortization over 3 years; seller commits to 12-month transition including introduction of the buyer to school district contacts and referring pediatricians; no earnout given the practice has 4 employed SLPs with independent caseloads and the owner drives fewer than 25% of billable hours

PE-Backed Therapy Platform Acquiring a High-Growth Adult Rehabilitation Speech Practice with Equity Rollover

$4,500,000 implied enterprise value at close

Cash to seller at close: $3,600,000 (80%) for 80% controlling interest | Seller retains 20% equity stake valued at $900,000 implied at close

Seller transitions into clinical director role at $120,000 annual compensation for 18 months; seller's retained equity is subject to a 3-year drag-along with a defined floor multiple of 5x EBITDA on any future platform sale; seller entitled to pro-rata proceeds on exit; no earnout required given diversified referral base and strong employed clinician team; post-close incentive pool of $50,000 established to retain top 3 SLPs through 12-month anniversary

Distressed Acquisition of an Owner-Dependent Practice with Earnout to Bridge Valuation Gap

$1,600,000 total (base + earnout)

Cash at close: $1,120,000 (70%) via SBA 7(a) | Buyer equity: $200,000 (12.5%) | Earnout: $280,000 (17.5%) paid over 18 months

Earnout structured as $15,556/month if trailing 3-month revenue meets or exceeds 90% of pre-close monthly average; earnout pauses in any month revenue falls below 85% threshold; seller agrees to 20-hour/week clinical and referral development commitment for 18 months at $65/hour; earnout payments are not contingent on seller's clinical hours but on aggregate practice performance; seller note waived in exchange for earnout structure; Medicaid payer mix capped at 40% as a covenant for first 24 months

Negotiation Tips for Speech Therapy Practice Deals

1Before negotiating price, agree on how EBITDA is calculated — in speech therapy practices, owner compensation add-backs, personal vehicle expenses, and above-market owner clinical salaries can swing adjusted EBITDA by $100,000–$300,000, which at a 5x multiple dramatically affects purchase price. Get the add-back schedule in writing early.
2Push for a detailed breakdown of revenue by payer type before finalizing structure — a practice with 50%+ Medicaid concentration warrants a lower multiple and potentially a larger earnout component to account for reimbursement rate risk, while a practice with strong private-pay and school district contract revenue can support a cleaner, higher-multiple deal.
3In earnout negotiations, always define clinician retention as a named-employee metric rather than a headcount-only metric — retaining 3 SLPs means nothing if the 3 highest-producing clinicians all left and were replaced by new hires who haven't built their caseloads yet. Tie earnout triggers to billed revenue per retained clinician.
4If the seller insists on a stock sale, negotiate a billing compliance representation and warranty with a 24-month survival period and meaningful indemnification cap — EHR documentation gaps or upcoding exposure in speech therapy practices can trigger payer audits that surface 12–18 months after close, and the buyer needs contractual protection.
5For equity rollover deals, negotiate the seller's post-close role with a written job description and clear authority matrix before signing the LOI — ambiguity about whether the seller-turned-clinical-director can hire, fire, or set clinical protocols creates destructive conflict with the new operator within the first 90 days.
6When structuring a consulting agreement as part of an asset purchase, ensure it is structured as a W-2 employment agreement rather than a 1099 contractor arrangement — payers including Medicare and Medicaid may require the transitioning clinician to be credentialed as an employee of the acquiring entity to supervise clinical staff and bill appropriately during the re-credentialing window.

Find Speech Therapy Practice Businesses For Sale

Pre-screened targets ready for your deal structure — free to join.

Get Deal Flow

Frequently Asked Questions

What is the typical purchase price multiple for a speech therapy practice?

Speech therapy practices in the lower middle market typically trade between 3.5x–6x adjusted EBITDA. Where a specific practice lands in that range depends heavily on owner independence, clinician team depth, payer mix diversification, and the durability of referral relationships. A practice with 5 employed SLPs, school district contracts, and an owner who bills less than 20% of total hours might command 5.5x–6x. A practice where the owner drives 45% of revenue with no succession plan may struggle to achieve 3.5x without a meaningful earnout component.

Can I use an SBA 7(a) loan to buy a speech therapy practice?

Yes — speech therapy practices are SBA-eligible businesses, and SBA 7(a) loans are the most common financing tool for individual buyers in this space. To qualify, the practice typically needs at least 2–3 years of positive cash flow, clean financial records, and an owner willing to sign a non-compete agreement. The buyer must inject 10–20% equity and personally guarantee the loan. Practices with heavy Medicaid concentration or outstanding billing audits may face SBA lender hesitation, so resolving compliance issues before going to market materially improves financing outcomes.

Why is an earnout commonly used in speech therapy practice acquisitions?

Earnouts are used when there is meaningful uncertainty about how revenue will hold after the owner transitions out. In speech therapy, this often stems from the founder having personal relationships with key referral sources — pediatricians, ENT groups, school district administrators — or maintaining a significant personal clinical caseload. An earnout protects the buyer from paying a full multiple for revenue that may not survive the ownership change, while giving the seller the opportunity to earn full value if the transition goes smoothly. The most defensible earnouts are tied to specific, measurable metrics like trailing revenue retention or SLP headcount above a defined floor.

How does payer mix affect the deal structure for a speech therapy practice?

Payer mix is one of the most important valuation and structuring variables in a speech therapy acquisition. Practices with diversified revenue across commercial insurance, private pay, and school district contracts command stronger multiples and cleaner structures. Heavy Medicaid concentration — particularly above 40–50% of revenue — increases risk due to reimbursement rate volatility, audit exposure, and administrative burden, which typically warrants a lower base multiple and may push buyers toward earnout or seller note structures that defer a portion of value until revenue quality is validated post-close.

What happens to patient records and HIPAA compliance during a speech therapy practice sale?

HIPAA compliance during a practice sale requires careful planning. If the transaction is structured as a stock purchase where the legal entity transfers to the buyer, patient records transfer with the entity and HIPAA obligations carry over. In an asset purchase, patients must be notified of the ownership change and given the opportunity to request record transfers or continued care elsewhere. The practice must have updated business associate agreements in place with all vendors and the acquiring entity before records are accessed. Buyers should conduct a HIPAA compliance audit during due diligence — EHR documentation gaps, outdated BAAs, or lack of breach notification policies are common findings that affect both deal terms and integration timelines.

How should a seller prepare their speech therapy practice for an acquisition?

Sellers who prepare 12–24 months in advance consistently achieve better pricing and deal terms. The most impactful steps include reducing your personal billable caseload to less than 25% of total practice revenue, ensuring all referral relationships are documented and tied to the practice entity rather than you personally, auditing billing and coding practices for payer compliance, organizing three years of clean accrual-based financials with owner compensation add-backs clearly documented, and identifying a clinical lead or office manager capable of running day-to-day operations independently. Practices with school district contracts or government service agreements should renew those agreements with multi-year terms before going to market.

More Speech Therapy Practice Guides

Acquire a Speech Therapy Practice Business →Valuation Guide →SBA Loan Guide →LOI Template →Due Diligence →

More Deal Structure Guides

Sporting Goods Store →Sports Training Facility →Staffing Agency →Storage & Warehousing →Stucco & Plastering Contractor →Summer Camp Business →Surveillance & Access Control →Swim School →Browse all deal structure guides →

Start Finding Speech Therapy Practice Deals Today — Free to Join

Find the right target, structure the deal, and close with confidence.

Create your free account

No credit card required